BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30777167)

  • 1. Economics of Community Health Workers for Chronic Disease: Findings From Community Guide Systematic Reviews.
    Jacob V; Chattopadhyay SK; Hopkins DP; Reynolds JA; Xiong KZ; Jones CD; Rodriguez BJ; Proia KK; Pronk NP; Clymer JM; Goetzel RZ
    Am J Prev Med; 2019 Mar; 56(3):e95-e106. PubMed ID: 30777167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease.
    Jacob V; Reynolds JA; Chattopadhyay SK; Hopkins DP; Therrien NL; Jones CD; Durthaler JM; Rask KJ; Cuellar AE; Clymer JM; Kottke TE;
    Am J Prev Med; 2022 Mar; 62(3):e202-e222. PubMed ID: 34876318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community Guide Cardiovascular Disease Economic Reviews: Tailoring Methods to Ensure Utility of Findings.
    Chattopadhyay SK; Jacob V; Mercer SL; Hopkins DP; Elder RW; Jones CD;
    Am J Prev Med; 2017 Dec; 53(6S2):S155-S163. PubMed ID: 29153116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Community Health Workers in controlling diabetes epidemic on the U.S.-Mexico border.
    Ryabov I
    Public Health; 2014 Jul; 128(7):636-42. PubMed ID: 24999158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
    Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
    Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engaging Community Health Workers to Increase Cancer Screening: A Community Guide Systematic Economic Review.
    Attipoe-Dorcoo S; Chattopadhyay SK; Verughese J; Ekwueme DU; Sabatino SA; Peng Y;
    Am J Prev Med; 2021 Apr; 60(4):e189-e197. PubMed ID: 33309455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force.
    Li R; Qu S; Zhang P; Chattopadhyay S; Gregg EW; Albright A; Hopkins D; Pronk NP
    Ann Intern Med; 2015 Sep; 163(6):452-60. PubMed ID: 26167962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Expenditure and Productivity Cost Savings from Reductions in Cardiovascular Disease and Type 2 Diabetes Associated with Increased Intake of Cereal Fibre among Australian Adults: A Cost of Illness Analysis.
    Fayet-Moore F; George A; Cassettari T; Yulin L; Tuck K; Pezzullo L
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29301298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Within trial cost-utility analysis of disease management program for patients hospitalized with atrial fibrillation: results from the SAFETY trial.
    Byrnes J; Ball J; Gao L; Kai Chan Y; Kularatna S; Stewart S; Scuffham PA
    J Med Econ; 2019 Sep; 22(9):945-952. PubMed ID: 31190590
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
    de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
    Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of Multicomponent Interventions to Increase Breast, Cervical, and Colorectal Cancer Screening: A Community Guide Systematic Review.
    Mohan G; Chattopadhyay SK; Ekwueme DU; Sabatino SA; Okasako-Schmucker DL; Peng Y; Mercer SL; Thota AB;
    Am J Prev Med; 2019 Oct; 57(4):557-567. PubMed ID: 31477431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of interventions to control cardiovascular diseases and type 2 diabetes mellitus in South Asia: protocol for a systematic review.
    Singh K; Chandra Sekaran AM; Bhaumik S; Aisola M; Chattopadhyay K; Gamage AU; de Silva P; Selvaraj S; Roy A; Prabhakaran D; Tandon N
    BMJ Open; 2015 Mar; 5(3):e007205. PubMed ID: 25757948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic Review.
    Jacob V; Chattopadhyay SK; Thota AB; Proia KK; Njie G; Hopkins DP; Finnie RKC; Pronk NP; Kottke TE;
    Am J Prev Med; 2015 Nov; 49(5):772-783. PubMed ID: 26477804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS).
    Raikou M; McGuire A; Colhoun HM; Betteridge DJ; Durrington PN; Hitman GA; Neil HA; Livingstone SJ; Charlton-Menys V; Fuller JH;
    Diabetologia; 2007 Apr; 50(4):733-40. PubMed ID: 17265034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a quality improvement collaborative focusing on patients with diabetes.
    Schouten LM; Niessen LW; van de Pas JW; Grol RP; Hulscher ME
    Med Care; 2010 Oct; 48(10):884-91. PubMed ID: 20808258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of interventions to control cardiovascular diseases and diabetes mellitus in South Asia: a systematic review.
    Singh K; Chandrasekaran AM; Bhaumik S; Chattopadhyay K; Gamage AU; Silva P; Roy A; Prabhakaran D; Tandon N
    BMJ Open; 2018 Apr; 8(4):e017809. PubMed ID: 29615442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of nurse practitioner/community health worker care to reduce cardiovascular health disparities.
    Allen JK; Dennison Himmelfarb CR; Szanton SL; Frick KD
    J Cardiovasc Nurs; 2014 Jul; 29(4):308-14. PubMed ID: 23635809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.